000 | 01601 a2200433 4500 | ||
---|---|---|---|
005 | 20250513143202.0 | ||
264 | 0 | _c19980528 | |
008 | 199805s 0 0 eng d | ||
022 | _a0022-3050 | ||
024 | 7 |
_a10.1136/jnnp.64.5.573 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aColzi, A | |
245 | 0 | 0 |
_aContinuous subcutaneous waking day apomorphine in the long term treatment of levodopa induced interdose dyskinesias in Parkinson's disease. _h[electronic resource] |
260 |
_bJournal of neurology, neurosurgery, and psychiatry _cMay 1998 |
||
300 |
_a573-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntiparkinson Agents _xadministration & dosage |
650 | 0 | 4 |
_aApomorphine _xadministration & dosage |
650 | 0 | 4 | _aChronotherapy |
650 | 0 | 4 |
_aDopamine Agonists _xadministration & dosage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfusion Pumps, Implantable |
650 | 0 | 4 | _aInjections, Subcutaneous |
650 | 0 | 4 |
_aLevodopa _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeurologic Examination _xdrug effects |
650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aTurner, K | |
700 | 1 | _aLees, A J | |
773 | 0 |
_tJournal of neurology, neurosurgery, and psychiatry _gvol. 64 _gno. 5 _gp. 573-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/jnnp.64.5.573 _zAvailable from publisher's website |
999 |
_c9565399 _d9565399 |